First Horizon Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.66K Hold
1,500
﹤0.01% 1824
2025
Q1
$6.79K Hold
1,500
﹤0.01% 1725
2024
Q4
$10.6K Hold
1,500
﹤0.01% 1579
2024
Q3
$12.2K Buy
+1,500
New +$10.8K ﹤0.01% 1545
2022
Q1
Sell
-566
Closed -$22K 1956
2021
Q4
$22K Hold
566
﹤0.01% 1239
2021
Q3
$28K Hold
566
﹤0.01% 1147
2021
Q2
$31K Hold
566
﹤0.01% 950
2021
Q1
$26K Hold
566
﹤0.01% 983
2020
Q4
$24K Hold
566
﹤0.01% 833
2020
Q3
$20K Buy
+566
New +$19.2K ﹤0.01% 815

Other funds holding HCAT

First Horizon Advisors's HCAT Position: Q2 2025 in Review

First Horizon Advisors held its Health Catalyst (HCAT) position steady in Q2 2025 at 1,500 shares worth $5.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

First Horizon Advisors first reported a position in HCAT in Q3 2020 and has held it in 10 quarters since. The position peaked at $31K in Q2 2021. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

  • First Horizon Advisors held 1,500 shares of Health Catalyst worth $5.66K as of Q2 2025.
  • First Horizon Advisors left its Health Catalyst share count unchanged in Q2 2025.
  • Health Catalyst made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1824 holding.
  • First Horizon Advisors first reported a position in Health Catalyst in Q3 2020 and has held it in 10 quarters since.
  • First Horizon Advisors's Health Catalyst position peaked at $31K in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.